Navigation Links
AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2008
Date:8/4/2008

ble-for-sale securities 37,919 15,240

Cash provided by (used in)

investing activities 18,062 (1,329)

Financing activities

Repurchases of common stock (21,703) -

Exercise of stock options 181 182

Cash (used in) provided by

financing activities (21,522) 182

Increase (decrease) in cash and cash

equivalents (2,183) 3,492

Cash and cash equivalents at beginning

of period 8,536 7,331

Cash and cash equivalents at end of period $6,353 $10,823

Supplemental disclosure of cash paid during

the period for:

Income taxes, net of refunds $115 $60

Non-cash investing activities:

Unrealized gain (loss) on

available-for-sale securities $11 $(29)

2008

Projected

Reconciliation of projected net loss to projected EBITDA

Projected net loss $(900)

Interest income 2,300

Operating loss (3,200)

Non-cash stock compensation expense 1,400

Depreciation and amortization 1,100

Amortization of software development costs 2,200

Projected pro-forma EBITDA $1,500

Reconciliation of net (loss)

income to EBITDA

Three Months Ended Six Months Ended


'/>"/>

SOURCE AMICAS, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Arcadia Radiology Medical Group Chooses AMICAS
2. AMICAS Announces Integrations at More Than 100 MEDITECH Facilities
3. AMICAS Reports Financial Results for the First Quarter Ended March 31, 2008
4. AMICAS to Present at CIBC World Markets 18th Annual Healthcare Conference
5. eResearchTechnology Reports Second Quarter 2008 Results
6. SuperGen Reports 2008 Second Quarter Financial Results
7. Neurobiological Technologies Reports Receipt of $2.1 Million Royalty Payment for Quarterly Sales of Memantine
8. InterMune Reports Second Quarter 2008 Financial Results and Business Highlights
9. CV Therapeutics Reports 2008 Second Quarter Financial Results
10. Gentiva Reports Strong Second Quarter led by Home Health Segment
11. United Therapeutics Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... TN (PRWEB) , ... July 02, 2015 , ... ... the development and manufacturing of surgical instruments in Orthopedics, announced today the acquisition ... contract-manufacturing and the world's largest provider of surgical instruments to the Spine Industry. ...
(Date:7/1/2015)... and PARIS , July ... and Genective, key developer of biotech crops, today ... of new generations of insect control traits. ... to counter the realities of advancing insect resistance. ... AgBiome,s unique insect control technology with Genective,s capability ...
(Date:7/1/2015)... ... 2015 , ... The next-generation sequencing (NGS) clinical market is poised for huge ... industry. BCC Research reveals in its new report that the market drivers of this ... growing need for better diagnostics as part of a molecular diagnostics trend. , The ...
(Date:7/1/2015)... , July 1, 2015   Neuraltus Pharmaceuticals, ... development of groundbreaking drugs to treat neurodegenerative diseases ... that Robert G. Miller , M.D., Director of ... Health,s California Pacific Medical Center in San Francisco, has ... for $1.5 million to help fund a Phase ...
Breaking Biology Technology:In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3AgBiome and Genective collaborate to create novel insect-resistant crops 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 2NGS-Based Diagnostics, the ‘Must-Have Platform’, Sends Market Segment CAGRs Soaring According to BCC Research 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4
... /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE:, WX ... Operating Officer and,acting Chief Financial Officer, will present at ... Wednesday, June 17, 2009, at 11:45 am,Eastern Daylight Savings ... ) , The Company ...
... Three Rivers Pharmaceuticals announced today positive results of the ... Combined Therapy (DIRECT) clinical trial authored by Bruce R. ... colleagues at 44 centers in the United States. The ... achieved demonstrating that INFERGEN provides a second chance to ...
... ... including paternity and ancestry testing, this week through Father,s Day. , ... Fairfield, OH (PRWEB) June 16, 2009 -- Throughout the ... DNA tests that reveal the truth about paternity--and more. , , ,Father,s Day can take ...
Cached Biology Technology:Three Rivers Announces Positive Results from Phase 3 DIRECT Trial of Once-Daily INFERGEN(R) with Ribavirin in Hepatitis C Virus Treatment Failures 2Three Rivers Announces Positive Results from Phase 3 DIRECT Trial of Once-Daily INFERGEN(R) with Ribavirin in Hepatitis C Virus Treatment Failures 3Three Rivers Announces Positive Results from Phase 3 DIRECT Trial of Once-Daily INFERGEN(R) with Ribavirin in Hepatitis C Virus Treatment Failures 4DNA Diagnostics Center Offers Father's Day DNA Testing 2
(Date:6/30/2015)... June 30, 2015 To bolster its efforts and ... Corp. announced today the addition of two new team members. ... board advisor and David Raviv will act as ... HYPR Corp.,s commitment to providing the most secure solutions for ... co-founded Layer 7 Technologies, a provider of security and ...
(Date:6/25/2015)... June 25, 2015  Imagine a tool specifically designed ... healthier, happier life. That,s exactly what USANA,s True ... The cutting-edge, portable health program provides a personalized approached ... help improve your lifestyle and nutrition. ... gala Wednesday night, USANA,s THA was honored with the ...
(Date:6/24/2015)... Research and Markets( ... "Huawei Ascend Mate 7 Fingerprint Sensor - ... Huawei,s technological choice for the fingerprint ... Apple,s and Samsung,s one. The Ascend Mate 7 ... Cards, a main actor in capacitive sensing human ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2
... An international team of scientists, exploiting pioneering techniques at ... unlocking the secrets of oxygenation of the Earth,s oceans ... organisms is intimately linked to the rise of oxygen ... that the appearance of large predatory fish as well ...
... ATLANTA A Georgia State University professor has ... at the obesity trends from childhood to adolescence. ... the Andrew Young School of Policy Studies, received a ... with co-investigator Daniel Millimet of Southern Methodist University. ...
... of bacterial biofilms, structured aggregates of bacteria that live ... stresses. These biofilms impact human health in many ways ... which patients die from airway bacterial biofilm infections that ... Now, UCLA researchers and their colleagues have ...
Cached Biology News:Plants kick-start evolutionary drama of Earth's oxygenation 2Plants kick-start evolutionary drama of Earth's oxygenation 3UCLA-led research team finds that bacteria can stand up and walk 2UCLA-led research team finds that bacteria can stand up and walk 3
... insert sequencing service for large insert vectors ... Agencourt utilizes unique library construction techniques to ... several features that allow Agencourt to provide ... including our patented magnetic bead-based SPRI technology, ...
...
... Guava EasyCyte system is the first and ... built-in 96-well microplate sampling (with tube options). ... and compounds quickly and easily, without the ... the carryover issues found with other detachable ...
A flexible 24-48 hour DNA sequencing service. Samples may be shipped in standard 1.5mL tubes. Oligo synthesis and DNA preparation available. Read lengths up to 850 Phred 20 bases. Universal primers p...
Biology Products: